Epstein-Barr virus (EBV)-seronegative recipients of EBV-seropositive donor (EBV D+/R−) kidneys have an increased risk for posttransplant lymphoproliferative disorder (PTLD), according to a study ...
Organically Human on MSN5mon
MS reversed by transplanted immune cells that fight Epstein-Barr virusA new study found that part of the Epstein-Barr virus mimics a protein made in ... response against that target can ...
Notch Signaling in Other Human Tumor Viruses: Implications for Infection & Pathogenesis EBV has evolved specific ... Studies on the virus–host interactions therefore provide an unique ...
Most of these tumors are caused by oncogenic DNA viruses, including KS-associated herpesvirus and Epstein-Barr virus ... vascular or other pathogenesis-based targets. Cite this: Therapy Insight ...
Patients who receive kidney transplants from Epstein–Barr virus D-positive/R-negative donors face a higher risk of ...
In this retrospective cohort study, individuals who were Epstein-Barr virus-seronegative had higher rates of post-transplant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback